Immune-Related Adverse Events in Cancer Patients Treated With Immune Checkpoint Inhibitors

[1] Weiden J(2018)Synthetic immune niches for cancer immunotherapy Nat Rev Immunol 18 212-219

[2] Tel J(2016)Cancer immunotherapy: the beginning of the end of cancer? BMC Med 14 73-264

[3] Figdor CG(2012)The blockade of immune checkpoints in cancer immunotherapy Nat Rev Cancer 12 252-998

[4] Farkona S(2002)Cancer immunoediting: from immunosurveillance to tumor escape Nat Immunol 3 991-168

[5] Diamandis EP(2018)Immune-related adverse events associated with immune checkpoint blockade N Engl J Med 378 158-214

[6] Blasutig IM(2015)Immune checkpoint targeting in cancer therapy: toward combination strategies with curative potential Cell 161 205-988

[7] Pardoll DM(2016)CD28 costimulation: from mechanism to therapy Immunity 44 973-1028

[8] Dunn GP(2006)Cytokine storm in a phase 1 trial of the anti-CD28 monoclonal antibody TGN1412 N Engl J Med 355 1018-270

[9] Bruce AT(1987)A new member of the immunoglobulin superfamily--CTLA-4 Nature 328 267-465

[10] Ikeda H(1995)CD28 and CTLA-4 have opposing effects on the response of T cells to stimulation J Exp Med 182 459-79

[1] Weiden J(2018)Synthetic immune niches for cancer immunotherapy Nat Rev Immunol 18 212-219

[2] Tel J(2016)Cancer immunotherapy: the beginning of the end of cancer? BMC Med 14 73-264

[3] Figdor CG(2012)The blockade of immune checkpoints in cancer immunotherapy Nat Rev Cancer 12 252-998

[4] Farkona S(2002)Cancer immunoediting: from immunosurveillance to tumor escape Nat Immunol 3 991-168

[5] Diamandis EP(2018)Immune-related adverse events associated with immune checkpoint blockade N Engl J Med 378 158-214

[6] Blasutig IM(2015)Immune checkpoint targeting in cancer therapy: toward combination strategies with curative potential Cell 161 205-988

[7] Pardoll DM(2016)CD28 costimulation: from mechanism to therapy Immunity 44 973-1028

[8] Dunn GP(2006)Cytokine storm in a phase 1 trial of the anti-CD28 monoclonal antibody TGN1412 N Engl J Med 355 1018-270

[9] Bruce AT(1987)A new member of the immunoglobulin superfamily--CTLA-4 Nature 328 267-465

[10] Ikeda H(1995)CD28 and CTLA-4 have opposing effects on the response of T cells to stimulation J Exp Med 182 459-79